These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29778824)

  • 1. Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence.
    Moustafa MA; El-Refaie WM; Elnaggar YSR; Abdallah OY
    Int J Pharm; 2018 Jul; 546(1-2):166-175. PubMed ID: 29778824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
    Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
    Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing.
    Pathak MK; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2013 May; 39(5):780-90. PubMed ID: 22873799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE; Mohamed EA; Khatera NAA
    Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of antifungal fibrous ocular insert using freeze-drying technique.
    Teba HE; Khalil IA; Gebreel RM; Fahmy LI; Sorogy HME
    Drug Deliv Transl Res; 2024 Sep; 14(9):2520-2538. PubMed ID: 38366116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M; Mahmoodzadeh M; Farrahi F
    AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
    Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
    Abdelbary GA; Amin MM; Zakaria MY
    Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate.
    Wang X; Zhang Y; Huang J; Xia M; Liu L; Tian C; Hu R; Gui S; Chu X
    Int J Pharm; 2019 May; 562():31-41. PubMed ID: 30878587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment.
    Abdelbary AA; Abd-Elsalam WH; Al-Mahallawi AM
    Int J Pharm; 2016 Nov; 513(1-2):688-696. PubMed ID: 27717916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: In vitro characterization and in vivo permeation.
    Zhou T; Zhu L; Xia H; He J; Liu S; He S; Wang L; Zhang J
    Eur J Pharm Sci; 2017 Nov; 109():288-296. PubMed ID: 28823856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation.
    Bachhav YG; Patravale VB
    Int J Pharm; 2009 Jan; 365(1-2):175-9. PubMed ID: 18790032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.
    Lihong W; Xin C; Yongxue G; Yiying B; Gang C
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W; Guo X; Feng M; Mao N
    Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
    Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
    Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocubosomal based
    Hosny KM; Rizg WY; Alkhalidi HM; Abualsunun WA; Bakhaidar RB; Almehmady AM; Alghaith AF; Alshehri S; El Sisi AM
    Drug Deliv; 2021 Dec; 28(1):1836-1848. PubMed ID: 34515597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.
    El-Refaie WM; Elnaggar YS; El-Massik MA; Abdallah OY
    Pharm Res; 2015 Sep; 32(9):2901-11. PubMed ID: 25777613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.